Eli Lilly (LLY) Q2 2025 earnings report

Eli Lilly on Thursday hiked its 2025 guidance and posted second-quarter earnings that topped estimates on strong demand for its blockbuster weight loss and diabetes drugs. The company raised its fiscal 2025 sales guidance to $60 billion to $62 billion, from a previous outlook of $58 billion to $61 billion on underlying strength across its business….

Read Full News

Trump’s ‘reciprocal’ tariffs come into effect, hitting dozens of U.S. trading partners

U.S. President Donald Trump speaks to reporters ahed of boarding Marine One to depart for New Jersey, at the White House in Washington, D.C., U.S., August 1, 2025. Jonathan Ernst | Reuters U.S. President Donald Trump’s so-called “reciprocal” tariffs took effect on Thursday, imposing higher duties on many of the country’s trading partners’ exports to…

Read Full News